# A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

> **NCT07127978** · — · RECRUITING · sponsor: **ITF Therapeutics LLC** · enrollment: 300 (estimated)

## Conditions studied

- Duchene Muscular Dystrophy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07127978
- **Lead sponsor:** ITF Therapeutics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-23
- **Primary completion:** 2030-06-30
- **Final completion:** 2030-07-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07127978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07127978, "A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07127978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
